nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000894	0.000894	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADCY1—lung cancer	0.000885	0.000885	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APP—lung cancer	0.000884	0.000884	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOTCH3—lung cancer	0.000884	0.000884	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGF9—lung cancer	0.000877	0.000877	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GNG11—lung cancer	0.000875	0.000875	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SMARCA4—lung cancer	0.000863	0.000863	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PPP2R1B—lung cancer	0.000863	0.000863	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CXCL8—lung cancer	0.000859	0.000859	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AVP—lung cancer	0.000858	0.000858	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000856	0.000856	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—POMC—lung cancer	0.000852	0.000852	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—JUNB—lung cancer	0.000837	0.000837	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFC—lung cancer	0.000833	0.000833	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HSPB1—lung cancer	0.000832	0.000832	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTHLH—lung cancer	0.000823	0.000823	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CG—lung cancer	0.000812	0.000812	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADCY1—lung cancer	0.000786	0.000786	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CD—lung cancer	0.000786	0.000786	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ANXA1—lung cancer	0.000774	0.000774	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—POMC—lung cancer	0.000773	0.000773	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SMARCA4—lung cancer	0.000766	0.000766	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PPP2R1B—lung cancer	0.000766	0.000766	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STK11—lung cancer	0.00076	0.00076	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6R—lung cancer	0.000754	0.000754	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FLT1—lung cancer	0.00075	0.00075	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CG—lung cancer	0.000743	0.000743	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HSPB1—lung cancer	0.000739	0.000739	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOTCH3—lung cancer	0.000734	0.000734	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APP—lung cancer	0.000734	0.000734	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FOXO3—lung cancer	0.000734	0.000734	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTHLH—lung cancer	0.000731	0.000731	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF9—lung cancer	0.000728	0.000728	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAP2K1—lung cancer	0.000719	0.000719	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CD—lung cancer	0.000714	0.000714	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—POMC—lung cancer	0.000707	0.000707	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—JUNB—lung cancer	0.000695	0.000695	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AVP—lung cancer	0.000687	0.000687	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ANXA1—lung cancer	0.000687	0.000687	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CB—lung cancer	0.000685	0.000685	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CG—lung cancer	0.000674	0.000674	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FLT1—lung cancer	0.000666	0.000666	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1R—lung cancer	0.000662	0.000662	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CG—lung cancer	0.00066	0.00066	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CXCL8—lung cancer	0.000659	0.000659	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CD—lung cancer	0.000653	0.000653	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOTCH3—lung cancer	0.000652	0.000652	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APP—lung cancer	0.000652	0.000652	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HES1—lung cancer	0.00065	0.00065	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF9—lung cancer	0.000646	0.000646	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—POMC—lung cancer	0.000642	0.000642	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—RAF1—lung cancer	0.000638	0.000638	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STK11—lung cancer	0.000631	0.000631	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—IL2—lung cancer	0.00063	0.00063	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—POMC—lung cancer	0.000628	0.000628	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6R—lung cancer	0.000626	0.000626	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CB—lung cancer	0.000622	0.000622	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—JUNB—lung cancer	0.000617	0.000617	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FOXO3—lung cancer	0.000609	0.000609	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	0.000599	0.000599	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CXCL8—lung cancer	0.000598	0.000598	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAP2K1—lung cancer	0.000597	0.000597	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ERBB3—lung cancer	0.000594	0.000594	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CD—lung cancer	0.000593	0.000593	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	0.00058	0.00058	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL2—lung cancer	0.000572	0.000572	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AVP—lung cancer	0.000571	0.000571	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—POMC—lung cancer	0.00057	0.00057	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TERT—lung cancer	0.00057	0.00057	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CB—lung cancer	0.000569	0.000569	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STK11—lung cancer	0.00056	0.00056	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6R—lung cancer	0.000556	0.000556	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGFR1—lung cancer	0.000553	0.000553	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1R—lung cancer	0.000549	0.000549	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	0.000547	0.000547	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HIF1A—lung cancer	0.000545	0.000545	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FOXO3—lung cancer	0.000541	0.000541	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HES1—lung cancer	0.00054	0.00054	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	0.00053	0.00053	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—RAF1—lung cancer	0.000529	0.000529	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	0.000527	0.000527	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOA1—lung cancer	0.000526	0.000526	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—IL2—lung cancer	0.000523	0.000523	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KDR—lung cancer	0.000521	0.000521	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	0.000517	0.000517	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AVP—lung cancer	0.000507	0.000507	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	0.000505	0.000505	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	0.000496	0.000496	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ERBB3—lung cancer	0.000493	0.000493	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1R—lung cancer	0.000488	0.000488	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	0.000486	0.000486	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CG—lung cancer	0.00048	0.00048	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APC—lung cancer	0.00048	0.00048	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KIT—lung cancer	0.00048	0.00048	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—NRAS—lung cancer	0.00048	0.00048	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HES1—lung cancer	0.000479	0.000479	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL2—lung cancer	0.000474	0.000474	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EGF—lung cancer	0.000474	0.000474	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TERT—lung cancer	0.000473	0.000473	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—RAF1—lung cancer	0.00047	0.00047	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—IL2—lung cancer	0.000464	0.000464	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAPK3—lung cancer	0.00046	0.00046	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGFR1—lung cancer	0.000459	0.000459	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	0.000459	0.000459	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—POMC—lung cancer	0.000457	0.000457	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HIF1A—lung cancer	0.000452	0.000452	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—BRAF—lung cancer	0.000451	0.000451	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6R—lung cancer	0.000446	0.000446	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CREBBP—lung cancer	0.000445	0.000445	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	0.000441	0.000441	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ERBB3—lung cancer	0.000438	0.000438	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—EGFR—lung cancer	0.000437	0.000437	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOA1—lung cancer	0.000436	0.000436	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KDR—lung cancer	0.000432	0.000432	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAP2K1—lung cancer	0.000425	0.000425	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CD—lung cancer	0.000422	0.000422	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL2—lung cancer	0.000421	0.000421	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TERT—lung cancer	0.00042	0.00042	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CA—lung cancer	0.000418	0.000418	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—KRAS—lung cancer	0.000413	0.000413	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGFR1—lung cancer	0.000408	0.000408	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HIF1A—lung cancer	0.000402	0.000402	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KIT—lung cancer	0.000398	0.000398	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	0.000398	0.000398	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APC—lung cancer	0.000398	0.000398	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—NRAS—lung cancer	0.000398	0.000398	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EGF—lung cancer	0.000394	0.000394	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOA1—lung cancer	0.000388	0.000388	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KDR—lung cancer	0.000384	0.000384	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	0.000381	0.000381	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CA—lung cancer	0.000379	0.000379	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—POMC—lung cancer	0.000379	0.000379	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MDM2—lung cancer	0.000378	0.000378	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RAF1—lung cancer	0.000377	0.000377	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—BRAF—lung cancer	0.000374	0.000374	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ERBB2—lung cancer	0.000373	0.000373	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6R—lung cancer	0.00037	0.00037	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CREBBP—lung cancer	0.000369	0.000369	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MTOR—lung cancer	0.000368	0.000368	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CB—lung cancer	0.000368	0.000368	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—EGFR—lung cancer	0.000363	0.000363	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KIT—lung cancer	0.000354	0.000354	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APC—lung cancer	0.000354	0.000354	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	0.000354	0.000354	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	0.000354	0.000354	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CXCL8—lung cancer	0.000353	0.000353	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	0.000352	0.000352	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HRAS—lung cancer	0.000351	0.000351	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	0.00035	0.00035	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EGF—lung cancer	0.00035	0.00035	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	0.000347	0.000347	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	0.000343	0.000343	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT1—lung cancer	0.000341	0.000341	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	0.000339	0.000339	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CASP3—lung cancer	0.000338	0.000338	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL2—lung cancer	0.000338	0.000338	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—POMC—lung cancer	0.000337	0.000337	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—lung cancer	0.000336	0.000336	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—BRAF—lung cancer	0.000333	0.000333	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCND1—lung cancer	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6R—lung cancer	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—JUN—lung cancer	0.000329	0.000329	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	0.000328	0.000328	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	0.000322	0.000322	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MMP9—lung cancer	0.00032	0.00032	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CDKN1A—lung cancer	0.000318	0.000318	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTEN—lung cancer	0.000318	0.000318	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	0.000315	0.000315	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MDM2—lung cancer	0.000314	0.000314	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	0.000313	0.000313	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RAF1—lung cancer	0.000313	0.000313	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	0.000311	0.000311	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT1—lung cancer	0.00031	0.00031	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	0.000309	0.000309	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	0.000308	0.000308	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	0.000305	0.000305	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MTOR—lung cancer	0.000305	0.000305	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	0.000305	0.000305	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EP300—lung cancer	0.000303	0.000303	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SRC—lung cancer	0.000295	0.000295	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	0.000293	0.000293	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	0.000291	0.000291	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VEGFA—lung cancer	0.000287	0.000287	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STAT3—lung cancer	0.000284	0.000284	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NRAS—lung cancer	0.000283	0.000283	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	0.000283	0.000283	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CASP3—lung cancer	0.000281	0.000281	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL2—lung cancer	0.00028	0.00028	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	0.00028	0.00028	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—lung cancer	0.000279	0.000279	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MDM2—lung cancer	0.000279	0.000279	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RAF1—lung cancer	0.000278	0.000278	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	0.000275	0.000275	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCND1—lung cancer	0.000273	0.000273	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—JUN—lung cancer	0.000273	0.000273	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK3—lung cancer	0.000272	0.000272	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	0.000271	0.000271	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MTOR—lung cancer	0.000271	0.000271	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MMP9—lung cancer	0.000265	0.000265	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	0.000264	0.000264	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MYC—lung cancer	0.000264	0.000264	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTEN—lung cancer	0.000264	0.000264	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	0.000261	0.000261	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	0.000259	0.000259	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EGFR—lung cancer	0.000258	0.000258	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	0.000257	0.000257	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	0.000252	0.000252	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EP300—lung cancer	0.000252	0.000252	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CASP3—lung cancer	0.000249	0.000249	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL2—lung cancer	0.000249	0.000249	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—lung cancer	0.000248	0.000248	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SRC—lung cancer	0.000245	0.000245	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KRAS—lung cancer	0.000244	0.000244	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCND1—lung cancer	0.000243	0.000243	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—JUN—lung cancer	0.000242	0.000242	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	0.000238	0.000238	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STAT3—lung cancer	0.000236	0.000236	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MMP9—lung cancer	0.000236	0.000236	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NRAS—lung cancer	0.000235	0.000235	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	0.000235	0.000235	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTEN—lung cancer	0.000234	0.000234	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	0.000229	0.000229	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	0.000225	0.000225	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	0.000224	0.000224	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EP300—lung cancer	0.000223	0.000223	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MYC—lung cancer	0.000219	0.000219	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SRC—lung cancer	0.000217	0.000217	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TP53—lung cancer	0.000217	0.000217	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EGFR—lung cancer	0.000214	0.000214	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	0.000212	0.000212	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT3—lung cancer	0.00021	0.00021	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NRAS—lung cancer	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HRAS—lung cancer	0.000207	0.000207	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KRAS—lung cancer	0.000203	0.000203	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	0.0002	0.0002	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—lung cancer	0.000199	0.000199	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MYC—lung cancer	0.000195	0.000195	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EGFR—lung cancer	0.00019	0.00019	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	0.000186	0.000186	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT1—lung cancer	0.000183	0.000183	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TP53—lung cancer	0.00018	0.00018	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KRAS—lung cancer	0.00018	0.00018	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HRAS—lung cancer	0.000172	0.000172	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	0.000165	0.000165	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—lung cancer	0.000165	0.000165	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TP53—lung cancer	0.00016	0.00016	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HRAS—lung cancer	0.000153	0.000153	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT1—lung cancer	0.000152	0.000152	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—lung cancer	0.000146	0.000146	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT1—lung cancer	0.000135	0.000135	CbGpPWpGaD
